Preliminary reports show conolidine may inhibit specific ion channels, cutting down neuronal excitability and restricting pain alerts. This system is especially appropriate in neuropathic agony, where irregular signaling results in persistent soreness. Additionally, conolidine appears to affect G protein-coupled receptor (GPCR) pathways integral to suffering perception. Computational ... https://nazimt738neu4.wikicommunications.com/user